ABIOMED, Inc. (NASDAQ: ABMD) Q1 2023 earnings call dated Aug. 04, 2022 Corporate Participants: Nicole Nath -- Manager of Investor Relations Michael R. Minogue -- Chairman,
ABIOMED, Inc. (ABMD) Q1 2023 Earnings Call Transcript

ABIOMED, Inc. (NASDAQ: ABMD) Q1 2023 earnings call dated Aug. 04, 2022 Corporate Participants: Nicole Nath -- Manager of Investor Relations Michael R. Minogue -- Chairman,
Boston Scientific Corp (NYSE: BSX) Q2 2022 earnings call dated Jul. 27, 2022 Corporate Participants: Lauren Tengler -- Director of Investor Relations Michael F.
Intuitive Surgical Inc. (NASDAQ: ISRG) reported revenue of $1.52 billion for the second quarter of 2022, up 4% year-over-year. GAAP net income
Abbott (NYSE: ABT) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions Robert
AngioDynamics Inc. (NASDAQ: ANGO) on Tuesday reported a modest profit for the fourth quarter of 2022 compared to breakeven last year. Revenues
Like most healthcare-related businesses, Abbott Laboratories (NYSE: ABT) has been operating near full capacity for quite some time, with its diagnostics segment
The performance of AngioDynamics, Inc. (NASDAQ: ANGO) has not been very impressive lately, despite being part of a rapidly growing industry. But
Intuitive Surgical, Inc. (NASDAQ: ISRG) is a market leader in the manufacturing and distribution of robotics-assisted surgical systems. The company’s products, designed for
As IPO activity picks up momentum after a lull, technology and healthcare companies are dominating the scene as usual. The upcoming initial
More than two years into the pandemic, the healthcare sector remains under stress due to continuing COVID care activities and hospitalizations. However,
Medical device maker Medtronic plc (NYSE: MDT) has reported an increase in profit for the fourth quarter of 2022, despite a modest
Medtronic PLC (NYSE: MDT) Q4 2022 earnings call dated May. 26, 2022 Corporate Participants: Ryan Weispfenning -- Vice President and Head - Investor Relations
Boston Scientific Corp. (NYSE: BSX) Q1 2022 earnings call dated Apr. 27, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a decline in first-quarter earnings despite a double-digit growth in revenues, hurt
Abbott Laboratories (NYSE: ABT) Q1 2022 earnings call dated Apr. 20, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations Robert B. Ford -- Chairman
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported higher earnings for the third quarter of 2022 when the medical device maker's net sales
The pandemic had a mixed impact on the healthcare sector. The high demand for COIVD care services sent medical facilities into overdrive,
Medtronic PLC (NYSE: MDT) Q3 2022 earnings call dated Feb. 22, 2022 Corporate Participants: Ryan Weispfenning -- Vice President and Head, Investor Relations Karen
Meihua International Medical Technologies is the latest healthcare company to seek Wall Street listing, even as the IPO market picks up momentum
Boston Scientific Corp (NYSE: BSX) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
Edwards Lifesciences Corporation (NYSE: EW) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Mark Wilterding -- Vice President, Investor Relations & Treasurer